Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alejandro Gutierrez

Showing results (111-120 of 124) with videos related to

Pageof 13
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 19, 2021
Impact of renin-angiotensin system inhibitors on mortality during the COVID Pandemic among STEMI patients undergoing mechanical reperfusion: Insight from an international STEMI registryGiuseppe De Luca, Miha Cercek, Lisette Okkels Jensen, et al.
Journal of the American College of Cardiology|November 13, 2020
Impact of COVID-19 Pandemic on Mechanical Reperfusion for Patients With STEMIGiuseppe De Luca, Monica Verdoia, Miha Cercek, et al.
Atherosclerosis|August 14, 2021
Impact of SARS-CoV-2 positivity on clinical outcome among STEMI patients undergoing mechanical reperfusion: Insights from the ISACS STEMI COVID 19 registryGiuseppe De Luca, Niels Debel, Miha Cercek, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|December 5, 2024
Impact of diabetes on epicardial reperfusion and mortality in a contemporary STEMI population undergoing mechanical reperfusion: Insights from the ISACS STEMI COVID 19 registryGiuseppe De Luca, Magdy Algowhary, Berat Uguz, et al.
Respiratory Research|August 15, 2022
Impact of chronic obstructive pulmonary disease on short-term outcome in patients with ST-elevation myocardial infarction during COVID-19 pandemic: insights from the international multicenter ISACS-STEMI registryGiuseppe De Luca, Matteo Nardin, Magdy Algowhary, et al.
Diabetes Epidemiology and Management|January 24, 2022
Renin-angiotensin system inhibitors and mortality among diabetic patients with STEMI undergoing mechanical reperfusion during the COVID-19 pandemicGiuseppe De Luca, Matteo Nardin, Magdy Algowhary, et al.
Current Vascular Pharmacology|July 7, 2026
Chronic Treatment with Renin-Angiotensin System Inhibitors at Hospital Admission is Associated with Improved Reperfusion and Mortality Among STEMI Patients Undergoing Mechanical Reperfusion: Insight from the ISACS-STEMI COVID-19 RegistryGiuseppe De Luca, Magdy Algowhary, Berat Uguz, et al.
Journal of Clinical Medicine|March 29, 2023
Age-Related Effects of COVID-19 Pandemic on Mechanical Reperfusion and 30-Day Mortality for STEMI: Results of the ISACS-STEMI COVID-19 RegistryGiuseppe De Luca, Magdy Algowhary, Berat Uguz, et al.
Journal of Clinical Medicine|November 26, 2022
Impact of Smoking Status on Mortality in STEMI Patients Undergoing Mechanical Reperfusion for STEMI: Insights from the ISACS-STEMI COVID-19 RegistryGiuseppe De Luca, Magdy Algowhary, Berat Uguz, et al.
Angiology|October 12, 2022
SARS-CoV-2 Positivity, Stent Thrombosis, and 30-day Mortality in STEMI Patients Undergoing Mechanical ReperfusionGiuseppe De Luca, Magdy Algowhary, Berat Uguz, et al.
Pageof 13

Showing results (111-120 of 124) with videos related to

Sort By:
Pageof 13
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 19, 2021
Impact of renin-angiotensin system inhibitors on mortality during the COVID Pandemic among STEMI patients undergoing mechanical reperfusion: Insight from an international STEMI registryGiuseppe De Luca, Miha Cercek, Lisette Okkels Jensen, et al.
Journal of the American College of Cardiology|November 13, 2020
Impact of COVID-19 Pandemic on Mechanical Reperfusion for Patients With STEMIGiuseppe De Luca, Monica Verdoia, Miha Cercek, et al.
Atherosclerosis|August 14, 2021
Impact of SARS-CoV-2 positivity on clinical outcome among STEMI patients undergoing mechanical reperfusion: Insights from the ISACS STEMI COVID 19 registryGiuseppe De Luca, Niels Debel, Miha Cercek, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|December 5, 2024
Impact of diabetes on epicardial reperfusion and mortality in a contemporary STEMI population undergoing mechanical reperfusion: Insights from the ISACS STEMI COVID 19 registryGiuseppe De Luca, Magdy Algowhary, Berat Uguz, et al.
Respiratory Research|August 15, 2022
Impact of chronic obstructive pulmonary disease on short-term outcome in patients with ST-elevation myocardial infarction during COVID-19 pandemic: insights from the international multicenter ISACS-STEMI registryGiuseppe De Luca, Matteo Nardin, Magdy Algowhary, et al.
Diabetes Epidemiology and Management|January 24, 2022
Renin-angiotensin system inhibitors and mortality among diabetic patients with STEMI undergoing mechanical reperfusion during the COVID-19 pandemicGiuseppe De Luca, Matteo Nardin, Magdy Algowhary, et al.
Current Vascular Pharmacology|July 7, 2026
Chronic Treatment with Renin-Angiotensin System Inhibitors at Hospital Admission is Associated with Improved Reperfusion and Mortality Among STEMI Patients Undergoing Mechanical Reperfusion: Insight from the ISACS-STEMI COVID-19 RegistryGiuseppe De Luca, Magdy Algowhary, Berat Uguz, et al.
Journal of Clinical Medicine|March 29, 2023
Age-Related Effects of COVID-19 Pandemic on Mechanical Reperfusion and 30-Day Mortality for STEMI: Results of the ISACS-STEMI COVID-19 RegistryGiuseppe De Luca, Magdy Algowhary, Berat Uguz, et al.
Journal of Clinical Medicine|November 26, 2022
Impact of Smoking Status on Mortality in STEMI Patients Undergoing Mechanical Reperfusion for STEMI: Insights from the ISACS-STEMI COVID-19 RegistryGiuseppe De Luca, Magdy Algowhary, Berat Uguz, et al.
Angiology|October 12, 2022
SARS-CoV-2 Positivity, Stent Thrombosis, and 30-day Mortality in STEMI Patients Undergoing Mechanical ReperfusionGiuseppe De Luca, Magdy Algowhary, Berat Uguz, et al.
Pageof 13